Literature DB >> 22565027

Growth and development: growth hormone therapy improves cognition in children with Prader-Willi syndrome.

Joana Osório.   

Abstract

Entities:  

Year:  2012        PMID: 22565027     DOI: 10.1038/nrendo.2012.73

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study.

Authors:  Elbrich P C Siemensma; Roderick F A Tummers-de Lind van Wijngaarden; Dederieke A M Festen; Zyrhea C E Troeman; A A E M Janielle van Alfen-van der Velden; Barto J Otten; Joost Rotteveel; Roelof J H Odink; G C B Karen Bindels-de Heus; Mariette van Leeuwen; Danny A J P Haring; Wilma Oostdijk; Gianni Bocca; E C A Mieke Houdijk; A S Paul van Trotsenburg; J J Gera Hoorweg-Nijman; Hester van Wieringen; René C F M Vreuls; Petr E Jira; Eelco J Schroor; Evelyn van Pinxteren-Nagler; Jan Willem Pilon; L Bert Lunshof; Anita C S Hokken-Koelega
Journal:  J Clin Endocrinol Metab       Date:  2012-04-16       Impact factor: 5.958

  1 in total
  4 in total

1.  Approach to the child with prader-willi syndrome.

Authors:  Jennifer L Miller
Journal:  J Clin Endocrinol Metab       Date:  2012-11       Impact factor: 5.958

Review 2.  Prader-Willi Syndrome: The Disease that Opened up Epigenomic-Based Preemptive Medicine.

Authors:  Takeo Kubota; Kunio Miyake; Natsuyo Hariya; Vuong Tran Nguyen Quoc; Kazuki Mochizuki
Journal:  Diseases       Date:  2016-03-11

Review 3.  Epigenetic alterations induced by environmental stress associated with metabolic and neurodevelopmental disorders.

Authors:  Takeo Kubota
Journal:  Environ Epigenet       Date:  2016-08-08

4.  Prader-Willi syndrome: reflections on seminal studies and future therapies.

Authors:  Michael S Chung; Maéva Langouët; Stormy J Chamberlain; Gordon G Carmichael
Journal:  Open Biol       Date:  2020-09-23       Impact factor: 6.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.